The Discounted Cash Flow (DCF) valuation of SpringWorks Therapeutics Inc (SWTX) is (170.11) USD. With the latest stock price at 46.11 USD, the upside of SpringWorks Therapeutics Inc based on DCF is -468.9%.
Based on the latest price of 46.11 USD and our DCF valuation, SpringWorks Therapeutics Inc (SWTX) is a sell. selling SWTX stocks now will result in a potential gain of 468.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.4% | 5.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,153.62) - (95.45) | (170.11) |
| Upside | -2601.9% - -307.0% | -468.9% |